Sa1195 Exposure-Efficacy Relationship (ER) for Adalimumab During Induction Phase of Treatment of Adult Patients With Moderate to Severe Ulcerative Colitis

Authors :: Walid M. Awni
Doerthe Eckert
Sven Mensing
Jean-Frederic Colombel
Nael M. Mostafa
Stephen B. Hanauer
Anne M. Robinson
William J. Sandborn
Roopal Thakkar
Rajendra S. Pradhan
Source :: Gastroenterology. 144:S-225
Publication Year :: 2013
Publisher :: Elsevier BV, 2013.

Subjects :: Moderate to severe
medicine.medical_specialty
Hepatology
Adult patients
business.industry
Gastroenterology
Induction Phase
medicine.disease
Ulcerative colitis
Internal medicine
medicine
Adalimumab
business
medicine.drug

Full Text Access

Tools